WOLFGANG WINKELMAYER to Dose-Response Relationship, Drug
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Dose-Response Relationship, Drug.
Connection Strength
0.844
-
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis. Kidney Int. 2024 07; 106(1):145-153.
Score: 0.168
-
Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysis. J Am Heart Assoc. 2014 Oct 21; 3(5):e001356.
Score: 0.087
-
Correlates and variance decomposition analysis of heparin dosing for maintenance hemodialysis in older US patients. Pharmacoepidemiol Drug Saf. 2014 May; 23(5):515-25.
Score: 0.084
-
IV iron dosing regimens: choice of agent and dosing frequency. Nephrol News Issues. 2014 Feb; 28(2):10-1, 18.
Score: 0.083
-
Commentary on 'The DOPPS practice monitor for U.S. dialysis care: update on trends in anemia management 2 years into the bundle': iron(y) abounds 2 years later. Am J Kidney Dis. 2013 Dec; 62(6):1217-20.
Score: 0.082
-
Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis. Am J Kidney Dis. 2012 Sep; 60(3):473-86.
Score: 0.074
-
Against TREATing all patients alike: lessons from an FDA Advisory Committee Meeting. J Am Soc Nephrol. 2011 Jan; 22(1):1-2.
Score: 0.067
-
The challenges of cost-effectiveness analyses for the clinician. Am J Kidney Dis. 2010 Dec; 56(6):1023-5.
Score: 0.067
-
Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int. 2003 Sep; 64(3):1046-9.
Score: 0.040
-
Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease. Heart. 2017 06; 103(11):818-826.
Score: 0.025
-
Comparative Effectiveness of Iron and Erythropoiesis-Stimulating Agent Dosing on Health-Related?Quality of Life in Patients Receiving?Hemodialysis. Am J Kidney Dis. 2016 Feb; 67(2):271-82.
Score: 0.023
-
Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients. PLoS One. 2013; 8(11):e78930.
Score: 0.020
-
Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol. 2006 Mar; 17(3):889-99.
Score: 0.012
-
The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients. Kidney Int. 2003 Jul; 64(1):295-304.
Score: 0.010